课题基金 / 基金详情

项目摘要

项目成果

ERIK K FLEMINGTON的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):EB病毒(EBV)在艾滋病相关非霍奇金淋巴瘤中具有高度渗透性,是肿瘤表型的关键驱动因素。虽然EBV潜伏基因对于促进肿瘤表型至关重要,但从潜伏期到裂解周期的转换是成功的EBV感染程序的关键方面。因此,驱动这种转换的机制多年来一直是积极研究的主题。尽管可以在组织培养中通过刺激B细胞受体(使用抗免疫球蛋白)或TGF-β受体(使用异位TGF-β)来实现EB病毒的再激活,但尚不确定此类事件在体内EB病毒感染的淋巴细胞中的常见程度(来自大卫的工作Thorley-Lawson的实验室)。本申请的首要假设是EBV已经进化出潜伏感染的B细胞的传感机制,以检测它们何时遇到上皮细胞环境。该模型提出,来自口腔/扁桃体上皮的环境线索(例如,在生发中心反应的晚期)触发B细胞的再活化,从而促进B细胞到上皮细胞的病毒转移,这是口腔上皮斑块形成和宿主到宿主传播的基本第一步。
英文摘要
DESCRIPTION (provided by applicant): The Epstein-Barr virus (EBV) is highly penetrant in AIDS-associated non-Hodgkin's lymphomas where it is a key driver of the tumor phenotype. While EBV latency genes are critical for facilitating the tumor phenotype, the switch from latency to the lytic cycle is a critical aspect of a successful EBV infection program. As a result, the mechanisms driving this switch have been topics of active investigation over the years. Although EBV reactivation can be achieved in tissue culture through stimulation of the B-cell receptor (with anti-Ig) or the TGF-beta receptor (with ectopic TGF-beta), it is uncertain how common such events are in EBV-infected lymphocytes in vivo (work from David Thorley-Lawson's lab). The overarching hypothesis of this application is that EBV has evolved with a sensing mechanism for latently infected B-cells to detect when they encounter an epithelial cell environment. This model proposes that environmental cues from the oral/tonsil epithelium (in the late stages of the germinal center reaction, for example) trigger reactivation in B-cells, thereby facilitating the B-cell to epithelial cell viral transfer that is a fundamental first step n oral epithelial plaque formation and host- to-host transmission.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EBV reactivation causes widespread host de novo promoter transcription and transcriptional interference
  • 批准号:
    10647826
  • 项目类别:
  • 资助金额:
    $41.28万
  • 财政年份:
    2022
  • 负责人:
    ERIK K FLEMINGTON
  • 依托单位:
EBV reactivation causes widespread host de novo promoter transcription and transcriptional interference
  • 批准号:
    10548370
  • 项目类别:
  • 资助金额:
    $42.13万
  • 财政年份:
    2022
  • 负责人:
    ERIK K FLEMINGTON
  • 依托单位:
Programmed splicing derangement as new EBV host cell shut-off mechanism
  • 批准号:
    10580068
  • 项目类别:
  • 资助金额:
    $41.79万
  • 财政年份:
    2022
  • 负责人:
    ERIK K FLEMINGTON
  • 依托单位:
Programmed splicing derangement as new EBV host cell shut-off mechanism
  • 批准号:
    10446536
  • 项目类别:
  • 资助金额:
    $42.65万
  • 财政年份:
    2022
  • 负责人:
    ERIK K FLEMINGTON
  • 依托单位:
海外基金